Shukra Pharmaceuticals has informed that in continuation to the communication dated March 17, 2025 with respect to Sub-Division of Equity Shares from the Face Value of Rs 10 each to Face Value of Rs 1 each fully paid up with effect from Record Date, March 21, 2025. Further informed that the Sub-Division of Equity Shares will take effect under the new ISIN i.e. INE551COLO44. It has attached the ISIN activation letter, received today, March 18, 2025 from the National Securities Depository Limited and Central Depository Services (India). This is in terms of Regulation 30, Regulations 42 and any other applicable regulation of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2025.
The above information is a part of company’s filings submitted to BSE.
